Panagiotis Malandrakis, MD^1*, Ioannis Ntanasis-Stathopoulos, MD, PhD, MSc^1*, Ioannis V Kostopoulos, PhD^2*, Vasiliki Spiliopoulou, MD^1*, Despina Fotiou, MD^1*, Foteini Theodorakakou, MD^1*, Magdalini Migkou, MD^1*, Nikolaos Kanellias^1*, Evangelos Eleutherakis-Papaiakovou, MD^1*, Efstathios Kastritis, MD^1*, Maria Gavriatopoulou^1*, Ourania Tsitsilonis, MD, PhD^2*, Meletios Dimopoulos, MD¹ and Evangelos Terpos, MD, PhD¹

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Department of Biology, School of Science, National and Kapodistrian University of Athens (NKUA), Athens, Greece

Sonja Zweegman, MD, PhD¹, Thierry Facon, MD², Vania Hungria, MD, PhD³, Nizar J. Bahlis, MD⁴, Christopher P. Venner, MD^5,6, Marc Braunstein^7*, Luděk Pour, MD^8*, Josep Marti Tutusaus^9*, Supratik Basu, MBBS, MD, FRCP, FRCPath^10*, Yael C. Cohen¹¹, Morio Matsumoto^12*, Kenshi Suzuki, MD, PhD¹³, Cyrille Hulin, MD^14*, Sebastian Grosicki, MD, PhD^15*, Wojciech Maciej Legiec, MD^16*, Meral Beksac^17*, Angelo Maiolino, MD, PhD^18*, Hiroyuki Takamatsu, MD, PhD¹⁹, Aurore Perrot, MD, PhD²⁰, Mehmet Turgut, MD^21*, Weiping Liu^22*, Jianping Wang^23*, Katherine Chastain, MD²³, Jessica Vermeulen, MD, PhD²⁴, Maria Krevvata, PhD^23*, Lorena Lopez-Masi^25*, Jodi Carey, BSN, RN^23*, Melissa Rowe^26*, Robin Carson, MD²³ and Saad Z. Usmani, MD²⁷

¹Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands
²University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France
³Clinica São Germano, São Paulo, Brazil
⁴Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, Canada
⁵Department of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
⁶BC Cancer – Vancouver Centre, University of British Columbia,, Vancouver, BC, Canada
⁷Department of Medicine, Division of Oncology-Hematology, NYU Long Island School of Medicine, Perlmutter Cancer Center, NYU Langone Hospital-Long Island, Mineola, NY
⁸University Hospital Brno, Brno, Czech Republic
⁹Hospital Mútua de Terrassa, Barcelona, Spain
¹⁰Royal Wolverhampton NHS Trust and University of Wolverhampton, CRN West Midlands, NIHR, Wolverhampton, United Kingdom
¹¹Department of Hematology, Tel-Aviv Sourasky (Ichilov) Medical Center, and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
¹²Department of Hematology, National Hospital Organization Shibukawa Medical Center, Gunma, Japan
¹³Japanese Red Cross Central Medical Center, Shibuya, Tokyo, Japan
¹⁴Hôpital Haut Lévêque, University Hospital, Pessac, France
¹⁵Department of Hematology and Cancer Prevention in Chorzów, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, Katowice, Poland
¹⁶Department of Hemato-Oncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland
¹⁷Ankara Liv Hospital, Istinye University, Ankara, Turkey
¹⁸Instituto Americas de Ensino, Pesquisa e Inovação, Rio de Janeiro, Brazil
¹⁹Department of Hematology, Kanazawa University Hospital, Kanazawa University, Kanazawa, Japan
²⁰CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
²¹Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey
²²Janssen Research & Development, LLC, Shanghai, China
²³Janssen Research & Development, LLC, Spring House, PA
²⁴Janssen Research & Development, LLC, Leiden, Netherlands
²⁵Janssen Research & Development, LLC, Raritan, NJ
²⁶Janssen Research & Development, High Wycombe, United Kingdom
²⁷Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Luciano J. Costa, MD, PhD¹, Eva Medvedova, MD^2*, Binod Dhakal, MBBS³, Bhagirathbhai R. Dholaria, MBBS⁴, Smith Giri^5*, Saurabh Chhabra, MD^6*, Susan Bal, MD⁷, Kelly Godby^5*, Gayathri Ravi, MD⁷, Rebecca W. Silbermann⁸ and Natalie Callander, MD⁹

¹Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Vestavia, AL
²Knight Cancer Institute, Oregon Health & Science University, Portland, OR
³Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁴Vanderbilt University Medical Center, Nashville, TN
⁵University of Alabama at Birmingham, Birmingham, AL
⁶Mayo Clinic, Phoenix, AZ
⁷Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
⁸Oregon Health and Science University, Portland, OR
⁹University of Wisconsin, Carbone Cancer Center, Madison, WI

Elias K. Mai, MD^1*, Hans Salwender, MD^2*, Michael Hundemer, MD^3*, Uta Bertsch, MD^4*, Ema Pozek^5*, Axel Benner^6*, Roland Fenk, MD, PhD^7*, Britta Besemer, MD^8*, Christine Hanoun^9*, Roland Schroers, MD^10*, Ivana von Metzler, MD^11*, Mathias Hänel, MD¹², Christoph Mann, MD^13*, Lisa Leypoldt, MD^14*, Bernhard Heilmeier^15*, Stefanie Huhn, PhD^16*, Sabine Vogel, PhD^17*, Christof Scheid^18*, Igor Wolfgang Blau, MD, PhD^19*, Steffen Luntz, MD^20*, Niels Weinhold, PhD^21*, Tobias A.W. Holderried, MD^22*, Karolin Trautmann-Grill^23*, Deniz Gezer, MD^24*, Maika Klaiber-Hakimi^25*, Martin Mueller, MD^26*, Evgenii Shumilov^27*, Wolfgang Knauf, MD^28*, Christian Sebastian Michel, MD^29*, Thomas Geer, MD³⁰, Hendrik Riesenberg^31*, Christoph Lutz^32*, Marc S. Raab^21*, Martin Hoffmann^33*, Katja C. Weisel, MD³⁴ and Hartmut Goldschmidt, MD²¹

¹Medicine V, University Hospital Heidelberg, Heidelberg, Germany
²Asklepios Tumorzentrum Hamburg, Asklepios Hospital Hamburg Altona and St. Georg, Hamburg, Germany
³Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
⁴Internal Medicine V, Hematology, Oncology and Rheumatology, GMMG Studygroup, Heidelberg University Hospital, Heidelberg, Germany
⁵German Cancer Research Center, Heidelberg, DEU
⁶Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
⁷Department of Haematology, Oncology, and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany
⁸Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany
⁹Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany
¹⁰Knappschaftskrankenhaus Bochum, University Hospital Bochum, Bochum, Germany
¹¹Department of Medicine II – Hematology and Oncology, Goethe-University Frankfurt, University Hospital, Frankfurt am Main, Germany
¹²Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany
¹³Department of Haematology, Oncology and Immunology, Philipps-University Marburg, Marburg, Germany
¹⁴University Medical Center Hamburg Eppendorf, Hamburg, Germany
¹⁵Clinic for Oncology and Hematology, Hospital Barmherzige Brueder Regensburg, Regensburg, Germany, Regensburg, DEU
¹⁶Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
¹⁷Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany, Heidelberg, Germany
¹⁸Cologne University Hospital, Cologne, Germany
¹⁹Medizinische Klinik m. S. Hämatologie , Onkologie und Tumorimmunologie, Berlin, Germany, Berlin, Germany
²⁰Coordination Centre for Clinical Trials (KKS), Heidelberg, Germany
²¹Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
²²Universitaetsklinikum Bonn (UKB), Bonn, Germany
²³University Hospital Carl Gustav Carus, Dresden, Germany
²⁴Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, DEU
²⁵Clinic for Hematology, Oncology and Palliative Care, Marien Hospital Düsseldorf, Düsseldorf, Germany, Duesseldorf, DEU
²⁶Klinikum Siloah Hannover, Hannover, Germany, Hannover, AL, DEU
²⁷Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
²⁸Center for Hematology and Oncology, Bethanien, Frankfurt a.M., Germany, Frankfurt a.M., Germany
²⁹Department of Internal Medicine III, University Hospital Mainz, Mainz, Germany
³⁰Medizinische Klinik Schwäbisch-Hall, Schwabisch Hall, DEU
³¹Hematology / Oncology Center, Bielefeld, Germany, Bielefeld, Germany
³²Hematology / Oncology Center, Koblenz, Germany, Koblenz, Germany
³³Medical Clinic A, Clinic Ludwigshafen, Ludwigshafen, Germany, Ludwigshafen, Germany
³⁴Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Noemi Puig, PhD^1,2, Bruno Paiva, PhD^3,4,5*, María T Cedena^6*, Cristina Agullo^7*, Teresa Contreras^7*, Sergio Castro^2*, Ana Maria Sureda Balari, MD, PhD^{8,9,10,11,12,13,14,15,16,17,18,19}, Veronica Gonzalez-Calle, MD, PhD^20*, Albert Oriol^21,22,23,24*, Enrique M Ocio, MD, PhD^25*, Laura Rosiñol Dachs^26,27,28,29*, Yolanda González-Montes, MD, PhD^30,31*, Joan Bargay^32*, Esther González García, MD, PhD^33*, Miguel Teodoro Hernández Garcia, MD, PhD^34*, Angel Ramirez, MD, PhD^35,36*, Alexia Suarez-Cabrera, MD, PhD^37*, María-Jesús Blanchard, MD, PhD^38*, Sebastián Garzón, MD, PhD^39*, Luis Felipe Casado Montero^40*, Valentin Cabanas Perianes, MD, PhD^41*, Jaime Perez de Oteyza^42*, Mercedes Gironella, MD^43*, Joaquín Martínez-Lopez^44,45*, Pilar Delgado, MD, PhD^46*, Elena Prieto, MD, PhD^47*, Juan-Jose Lahuerta Palacios, MD, PhD^48*, Joan Bladé, MD, PhD^49,50,51*, Jesús F. San-Miguel, MD, PhD^52,53,54 and Maria- Victoria Mateos^{1,55,56,57,58,59}

¹Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain, Salamanca, Spain
²Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain
³Clínica Universidad de Navarra. Centro de Investigación Médica Aplicada., Pamplona, Spain
⁴Cancer Center Clinica Universidad de Navarra (CCUN)., Pamplona, Spain
⁵Clinica Universidad de Navarra (CCUN), Center for Applied Medical Research (CIMA), IDISNA, CIBER-ONC, Pamplona, Spain
⁶University Hospital 12 de octubre, Madrid, Spain
⁷Biochemistry Department, University Hospital of Salamanca, Salamanca, ESP
⁸Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH-TC), Spain, Spain
⁹Hospital Duran i Reynals, Barcelona, Spain
¹⁰Clinical Hematology Department, Institut Català d'Oncologia-L'Hospitalet, IDIBALL, Universitat de Barcelona, Barcelona, Spain
¹¹Hospital de Sant Pau, Hematology Department, Autonomous University of Barcelona, Barcelona, Spain
¹²Blood Cell Barcelona Hematology Institute, Barcelona, Spain
¹³Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain
¹⁴Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH-TC), Madrid, Spain
¹⁵Bellvitge Health Sciences Campus, University of Barcelona, Barcelona, Spain
¹⁶EBMT Lymphoma Working Party, Paris, France
¹⁷Clinical Hematology Department, Institut Català d’Oncologia – L’Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain
¹⁸Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France
¹⁹Spanish CETLAM group, Spain, Spain
²⁰Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain
²¹Dana-Farber Cancer Institute, Boston, MA
²²Institut Josep Carreras and Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain
²³Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Baldona, Barcelona, Spain
²⁴Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
²⁵Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain
²⁶Hematopoietic Cell Transplantation Unit, Hospital Clínic de Barcelona, ICHMO, Barcelona, Spain
²⁷Hematology Department, Hospital Clinic de Barcelona and Insitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
²⁸Amyloidosis and Multiple Myeloma Unit, Department of Hematology, IDIBAPS, Hospital Clinic, Barcelona, Spain
²⁹Hospital Clinic de Barcelona and Insitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
³⁰Hematology, Institut d'Oncologia Dr. Josep Trueta, Girona, Spain
³¹Institut Català d'Oncologia Girona, Girona, Spain
³²Hematology Department, Hospital Universitario Son Llàtzer. IdIsBa., Palma de Mallorca, Spain
³³Hematology, University Hospital Cabueñes, Gijón, Spain
³⁴Hospital Universitario de Canarias, La Laguna, ESP
³⁵Hematology, Hospital Central de Asturias, Oviedo, Spain
³⁶Servicio de Hematología, Hospital Universitario Central de Asturias, Oviedo, Spain
³⁷Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas De Gran Canaria, Spain
³⁸Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain
³⁹Hematology, Hospital Universitario Jerez de la Frontera, Jerez de la Frontera, Cádiz, Spain
⁴⁰Hematology, Hospital General Universitario de Toledo, Toledo, Spain
⁴¹Hematology, IMIB-Virgen de la Arrixaca University Hospital, University of Murcia, El Palmar, Murcia, Spain
⁴²Universidad CEU San Pablo, Madrid, Spain
⁴³Hematology, Hospital Universitari Vall d'Hebron, Barcelona, Spain
⁴⁴University of Complutense, Hospital 12 de Octubre, Madrid, Spain
⁴⁵Department of Hematology, Hospital Universitario 12 de Octubre, CNIO, Universidad Complutense de Madrid, Madrid, Spain
⁴⁶Hematology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain
⁴⁷Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
⁴⁸Hematology, Hospital Universitario 12 de Octubre, Imas12, CIBERONC, Madrid, Spain
⁴⁹Amyloidosis and Multiple Myeloma Unit, Department of Hematology, IDIBAPS, Hospital Clinic, Spain, Barcelona, Spain
⁵⁰Hospital Clinic, IDIBAPS, Barcelona, Spain
⁵¹Hematology, Hospital Clínic de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona; and GEM/PETHEMA, Barcelona, Spain
⁵²Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain
⁵³Hematology and Cell Therapy Department. Clinica Universidad de Navarra. IdiSNA., Pamplona, Spain
⁵⁴Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra, CCUN, IDISNA, CIBER-ONC, Pamplona, Spain
⁵⁵Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain
⁵⁶Institute of Cancer Molecular and Cellular Biology, University Hospital of Salamanca, Salamanca, Spain
⁵⁷University of Salamanca, Department of Medicine, Salamanca, Spain
⁵⁸Complejo Asistencial Universitario de Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain
⁵⁹Centro de Investigacion Biomedica en Red de Cancer (CIBERONC)., Madrid, Spain

Daisuke Ikeda, M.D.^1,2*, Shuichi Aikawa^3*, Chiho Misono^3*, Mitsuaki Oura, M.D.^4*, Fuminari Fujii, M.D.^4*, Hajime Sakuma, M.D.^4*, Masanori Toho, MD^4*, Atsushi Uehara^5*, Rikako Tabata, M.D.^4*, Kentaro Narita, M.D.^4*, Masami Takeuchi, M.D.^4*, Tomohisa Watari^3*, Yoshihito Otsuka, Ph.D.^3* and Kosei Matsue, M.D., Ph.D.⁴

¹Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan
²Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
³Department of Laboratory Medicine, Kameda Medical Center, Chiba, Japan
⁴Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan
⁵Division of Hematology/Oncology, Kameda Medical Center, Kamogawa-Shi, Japan